Physician profile
Kevin D Brown
NPI 1811968555
$31,249.82
in general payments reported to CMS, 2019-2025
17 companies · $6,159 in 2025
The $6,159 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $6,104 · 2021: $6,106 · 2022: $402 · 2023: $6,580 · 2024: $5,715 · 2025: $6,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $551 · Education: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,400.00 |
| Food and Beverage | $550.87 |
| Education | $502.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Darco International, INC. | $29,400.00 | 2020-2025 | |
| Stryker Corporation | $551.68 | 2022-2023 | Infinity, T2 Alpha, Axs Infinity Ls |
| Organogenesis INC. | $403.82 | 2024-2025 | Cygnus Dual, Via Matrix, Affinity |
| Smith+Nephew, INC. | $348.74 | 2019-2022 | |
| Mid-Atlantic Surgical Systems, LLC | $117.74 | 2019-2020 | |
| Ethicon US, LLC | $88.95 | 2022 | |
| In2bones USA, LLC | $73.89 | 2019 | |
| Abbott Laboratories | $63.09 | 2022-2023 | Proclaim |
| Zimmer Biomet Holdings, INC. | $46.24 | 2020 | |
| Innovation Technologies INC | $28.73 | 2023 | Irrisept |
| Solventum Corporation | $24.31 | 2024 | V.A.C. Veraflo, Prevena |
| Amgen INC. | $23.32 | 2025 | Krystexxa |
| Globus Medical, INC. | $22.52 | 2025 | Senza |
| Convatec INC. | $16.81 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.26 | 2022 | |
| Bioventus LLC | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.